ArticleFrontiers in global women's health2026
Voluntary interruption of pregnancy using hysteroresectoscopy: a mini-series of 15 cases.
Article in Frontiers in global women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Although surgical techniques for later interruption have advanced since the legalisation of voluntary interruption of pregnancy (VIP), dilatation and curettage via aspiration (D&C) remains the conventional approach. Hysteroresectoscopy (HsR) presents a potential alternative. This study aims to evaluate the feasibility of using HsR to perform VIP in cases in the early first trimester. Design: A case series involving patients treated for VIP in our department. Patients: Women seeking VIP between six and ten weeks of amenorrhoea. Intervention: Hysteroscopic resection following cervical dilatation, performed as an outpatient procedure under general or spinal anaesthesia. Results: Between January 2021 and January 2026, 15 patients underwent VIP via HsR at our institution. One suspected case of uterine perforation was reported, and one patient experienced retained products of conception, which were managed with hysteroscopy performed in consultation without anesthesia. Additionally, 46,6% of patients received simultaneous contraception implantation. Conclusion: This mini-series suggests that HsR is a feasible technique for first trimester VIP, ideally applicable to pregnancies of up to nine of amenorrhoea. Fertility gains are expected from the minimal endometrial damage permitted by the technique. The findings are limited by the small sample size, making it difficult to draw definitive conclusions regarding the safety or efficacy of hysteroscopy compared with medical management or D&C. Although hysteroscopy appears to be a safe and promising approach, larger prospective studies are needed to confirm these findings and better compare outcomes with those of D&C.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.